Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Free Trade Talks In Asia And Europe Impeded By Government Shutdown

This article was originally published in The Gray Sheet

Executive Summary

As the shutdown continues, President Obama’s absence at negotiations on the Trans-Pacific Partnership could delay finalization of the free trade agreement. In addition, talks toward an EU-U.S. trade pact were canceled. Both agreements are expected to address device-specific trade issues.

You may also be interested in...



WikiLeaks Releases Draft Patent Chapter Of Trans-Pacific Free Trade Pact

The draft text highlights some key disagreements on intellectually property law questions between countries negotiating the comprehensive Trans-Pacific Partnership free trade agreement, including those related to method patents.

Shutdown Week Two: Could Sponsors Find A More Focused FDA?

User-fee supported employees continue to work on pending reviews, and the lack of distractions from other tasks may help sponsors as the shutdown continues.

U.S. Seeks Balance On Drug Access In Trans Pacific Partnership IP Talks

The United States remains hopeful that a sharp debate on access and stricter intellectual property rules in the TPP talks can be concluded by the end of the year after talks in Indonesia failed to break an impasse.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032495

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel